Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats-Reference-Cited by-同舟云学术

Potential value of Interleukin-6 as a diagnostic biomarker in human MDD and the antidepressant effect of its receptor antagonist tocilizumab in lipopolysaccharide-challenged rats

Published:2023-11 Issue: Volume:124 Page:110903
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Xu Dandan,Xu Yayun,Gao Xinran,Yan Mengyu,Zhang Chen,Wu Xian,Xia Qingrong,Ge Jinfang^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference90 articles.

1. Novel and emerging treatments for major depression;Marwaha;Lancet,2023

2. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019;Collaborators;Lancet Psychiatry,2022

3. Depression: ketamine steps out of the darkness;Malinow;Nature,2016

4. Ketamine treatment for depression: opportunities for clinical innovation and ethical foresight;Singh;Lancet Psychiatry,2017

5. Novel drug developmental strategies for treatment-resistant depression;Borbely;Br. J. Pharmacol.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tet1-mediated 5hmC regulates hippocampal neuroinflammation via wnt signaling as a novel mechanism in obstructive sleep apnoea leads to cognitive deficit;Journal of Neuroinflammation;2024-08-21

2. Protective effect of melatonin against metabolic disorders and neuropsychiatric injuries in type 2 diabetes mellitus mice;Phytomedicine;2024-08

3. Estrogen-immuno-neuromodulation disorders in menopausal depression;Journal of Neuroinflammation;2024-06-19

4. Psychedelic 25H-NBOMe attenuates post-sepsis depression in rats;Neuroscience Letters;2024-06

5. Assessing causality between chronic obstructive pulmonary disease with depression: A bidirectional Mendelian randomization study;Journal of Affective Disorders;2024-04